Login / Signup

Does the Spatial Distribution of Atrial Arrhythmogenic Substrate Matter? Insights from the DECAAF II trial.

Till F AlthoffAndreu Porta-Sánchez
Published in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2023)
Keyphrases
  • phase iii
  • study protocol
  • atrial fibrillation
  • phase ii
  • clinical trial
  • left atrial
  • randomized controlled trial
  • open label
  • heart failure
  • amino acid